NCT07555938
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07555938
Title Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma (CEVOLUTION)
Acronym CEVOLUTION
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center RECRUITING Duarte California 91010-3012 United States Details
City of Hope - Lennar Foundation Cancer Center RECRUITING Irvine California 92618 United States Details
Winship Cancer Institute of Emory University RECRUITING Atlanta Georgia 30329 United States Details
Auxilio Mutuo Cancer Center RECRUITING San Juan 00918 Puerto Rico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field